SCHEMBL18088829

SCHEMBL18088829

CC(C)(C)OC(=O)Nc1ccccc1NC(=O)c1cnccn1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MCL1 Q07820 1/20 0.61
▸ ALDH1A1 P00352 3/20 0.61
▸ ALOX15 P16050 2/20 0.61
▸ MAPT P10636 1/20 0.61
▸ HDAC3 O15379 1/20 0.60
▸ HDAC1 Q13547 1/20 0.60
▸ HDAC2 Q92769 1/20 0.60
▸ HDAC8 Q9BY41 1/20 0.60
▸ HDAC6 Q9UBN7 1/20 0.60
▸ TSHR P16473 3/20 0.57
▸ SMN1; SMN2 Q16637 2/20 0.57
▸ CYP1A2 P05177 1/20 0.53
▸ POLB P06746 1/20 0.53
▸ CYP3A4 P08684 1/20 0.53
▸ CYP2C9 P11712 1/20 0.53
▸ CYP2C19 P33261 1/20 0.53
▸ NPC1 O15118 2/20 0.52
▸ RAB9A P51151 2/20 0.52
▸ PKM P14618 1/20 0.51
▸ MEN1 O00255 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30127947 1.00 MCL1 (0.61) MCL1ALDH1A1ALOX15MAPTHDAC3
SCHEMBL6819396 0.84 RAB9A (0.66) ALDH1A1MAPTTSHRSMN1; SMN2POLB
SCHEMBL5227380 0.83 SMN1; SMN2 (0.47) MCL1ALDH1A1ALOX15MAPTSMN1; SMN2
SCHEMBL5224230 0.82 NAMPT (0.48) ALDH1A1ALOX15HDAC3HDAC1HDAC2
SCHEMBL28270381 0.81 MCL1 (0.71) MCL1ALDH1A1ALOX15MAPTHDAC3
SCHEMBL5229725 0.80 MEN1 (0.45) ALDH1A1SMN1; SMN2POLBNPC1RAB9A
SCHEMBL6365954 0.80 ALDH1A1 (0.45) MCL1ALDH1A1ALOX15MAPTTSHR
SCHEMBL18064949 0.79 MCL1 (0.73) MCL1ALDH1A1ALOX15MAPTHDAC3
SCHEMBL3716281 0.79 P4HTM (0.53) ALDH1A1HDAC1SMN1; SMN2NPC1RAB9A
SCHEMBL29768539 0.79 P4HTM (0.53) ALDH1A1HDAC1SMN1; SMN2NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9988343-B2 Inhibitors of histone deacetylase DANA-FARBER CANCER INSTITUTE, INC. (US) 2018-06-05 — — US disclosed
US-20160272579-A1 INHIBITORS OF HISTONE DEACETYLASE DANA-FARBER CANCER INSTITUTE, INC. 2016-09-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160272579-A1 INHIBITORS OF HISTONE DEACETYLASE HDAC1, HDAC5, HDAC3 MCL1 35/4885ALDH1A1 1006/4885ALOX15 3794/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback